Co-chairs: Nina R Schooler, PhD; Dawn Velligan PhD

This workshop will examine possible models and examples of  psychosocial treatment platforms for RCTS. It will consider  the advantages and disadvantages of specifying a uniform psychosocial platform in multi-center psychopharmacology clinical trials.  Advantages include minimizing error variance due to differences among sites in the kid of support provided and therefore reducing error.  Possible disadvantages include increased cost and the possibility that the platform will benefit a placebo treatment differentially.